In a survey, 73% of respondents had experienced at least one line clearance error in the previous 12 months. Automating this step can reduce errors while saving time in changeovers.

Line clearance in pharmaceutical industry is a set of activities or checks performed just before an operation can commence. Line clearance ensures the processing line is free of any irrelevant products, components, and documentation that could be left accidentally from an earlier batch. Line clearance is the first step in a process, and it is to be done before a line opening.

Eine neue Maschine zur Verpackung von Vials hat Schubert Pharma entwickelt. Line Clearance hat der Verpackungsexperte von Anfang an bei der Entwicklung mit berücksichtigt.

La pharma 4.0 améliore l’efficacité et l’agilité des entreprises pharmaceutiques grâce à une meilleure connectivité. Cela se traduit par une amélioration de la traçabilité et de la qualité, ainsi que des optimisations dans le stockage, la logistique et l’approvisionnement.

L’essor de l’intelligence artificielle, du Big Data, de la blockchain et de la télémédecine ouvre de nouvelles perspectives pour une médecine plus personnalisée, efficace et accessible. La digitalisation n’est plus une option mais une nécessité stratégique pour améliorer l’efficacité des soins.

Engineer Masahiro Hara created the QR code at Denso Wave to replace slow barcodes. It stores thousands of characters, scans from any angle, and was made royalty-free so the world could use it. And now? It powers everything from UPI to vaccine forms.

Amcor says recyclability claims were found to be more important to consumers for packaging than a reduction to carbon footprint, even though survey participants ranked ‘global warming’ as their top environmental concern – which has been consistent since the first edition of the research in 2020. Shoppers respond most positively to claims that relate to ‘recyclable packaging’ followed by ‘compostable packaging’, ‘packaging made of recycled materials’ and ‘paper-based packaging’.

The EU's pharma legislation wants to turn paper leaflets in medication packaging into QR codes — driven by Big Pharma influence — but patients argue this change creates unnecessary confusion, particularly for the elderly, and puts pressure on pharmacists.

A trio of drugmakers have issued separate recalls in the U.S. thanks to string of production flubs, including failed impurity and dissolution specifications and incorrect labelling of infusion bags.

The digital experience provided by AR packaging can take a variety of forms, including videos, animations, games, profiles, tours, etc., categorizable as information, entertainment, or a combination thereof. Packaging is a potent marketing tool, differentiating the branded product and serving as a visible cue of the product’s persona. The digital experience, therefore, should be consistent with that persona. As an example, it might be inconsistent for a pharmaceutical product to provide an experience meant to be entertaining and lighthearted, given the somber association between illness/discomfort and their alleviation.

One key driver is the increasing focus on regulatory compliance and the need for enhanced traceability in the pharmaceutical industry. Governments and regulatory bodies are imposing stringent requirements to ensure pharmaceutical products’ safety, authenticity, and traceability throughout the supply chain. The market’s expansion is fueled by the pharmaceutical sector’s commitment to meet evolving regulatory standards, combating counterfeiting, and safeguarding patient safety.

AIPIA member Digimarc is primarily known for its digital watermarking. However, the company’s Illuminate platform is not limited to digital watermarks. In fact the company says it is a pioneer and leading provider of GS1 Digital Link QR codes. From co-chairing the Digital Link standard, to leading the industry’s first commercial deployments of GS1 Digital Links with global brands like Ralph Lauren, Patagonia, Puma, AstraZeneca, Reckitt, and Unilever., it is at the forefront of this project, it claims.

Explore the critical challenges, current solutions, and cutting-edge technologies in the fight against counterfeit drugs. Learn about Physical-Chemical Identifiers (PCIDs), SECURtracers®, and how Micro-Tracers is revolutionizing drug safety. This video highlights the impact of counterfeit pharmaceuticals and the practical steps toward a more secure pharmaceutical supply chain.

By addressing the unique challenges of serialization in emerging markets, pharmaceutical companies can ensure global compliance, enhance supply chain integrity, and protect patients from counterfeit drugs. With the right strategies and technology, it’s possible to create a safer and more transparent pharmaceutical ecosystem worldwide.

In the pharmaceutical industry, where precision, compliance, and safety are paramount, master data management (MDM) plays a crucial role in ensuring seamless operations and regulatory adherence. Master data forms the backbone of serialization, aggregation, and reporting processes, making it an indispensable component for manufacturers striving to enhance efficiency while meeting stringent compliance requirements.

In today's fast-paced digital world, businesses need innovative tools to stay ahead of the competition. One such tool is QR track and trace solutions. This technology not only enhances your operations but also improves customer satisfaction. If you're looking to streamline processes and build trust, it's time to explore how QR tracking can benefit your business.

Serialization and traceability have become indispensable in the pharmaceutical industry, addressing critical issues like counterfeit medicines and regulatory compliance. These technologies not only secure the supply chain but also enhance patient safety and operational efficiency.

L’Agence nationale de sécurité du médicament (ANSM) indique que l’expérimentation commence en octobre 2025 pour deux ans. Un QR code imprimé sur les boîtes doit mener à une « e-notice ».

The way data was managed in the past was to keep on-premise IT infrastructure deployments which had problems with both pricing and performance. Adding to this was also the challenge of hiring efficient resources to manage both the systems and data deployed on premise. The data recorded in these systems was also not readily available for quick analysis and insight.

AIPIA member Adrich has announced a collaboration with Molex to ‘revolutionize smart label manufacturing’ and has launched a new trial of its smart label solutions. The company, which offers consumer insights and a smart replenishment platform powered by AI and IoT was a Brand Challenger at the recent AIPIA Congress. Molex is a global electronics company and connectivity innovator. Together the companies are aiming to greatly enhance the mass production of Adrich's patented smart labels using cutting-edge printed electronics.